The performance of companies tied to Sildenafil's legacy presents a complex investment picture . While the initial success generated substantial profits , generic competition have significantly impacted sales . Investing in connected pharmaceutical businesses now requires a careful assessment of proprietary rights , evolving patient shifts , and th